Update released earlier than last year , projected outflows this quarter are going to be about
$ 580 000 less than same time last year . Sales also better yet same time last year the stock price was around 0.50 .
It may be a good idea if Dennis Eck and Dr Martin Cross offer some opinions on the direction of Cellmid .
Mix it up a little as it seems Investors really have lost much confidence . Midkine Potential Announcements
considering Cellmid is a Biotech may also be a good idea .
